Thoracent

Minimally invasive devices for managing pleural effusions and restoring airway patency to improve quality of life, along with an expanded suite of GI tools.

Learn more about Thoracent

Diagnostics

Developing molecular diagnostic tool that aim to triage lung cancer in patients to identify those in need of immediate care.

Learn more about Diagnostics

Biopsy Tools

Developing a suite of steerable endobronchial instruments to target difficult-to-reach and off-airway nodules.

Learn more about our Biopsy Tools

Leadership

Maverix leadership combines decades of clinical, technical, and operating experience.

Learn more about our leadership

Advisors

The Maverix Medical Advisory Board is comprised of leading pulmonary physicians.

Meet our advisors

Partners

Maverix collaborates with firms that are transforming medtech innovation.

See our partners
Most Recent Article
Fierce Biotech
March 29, 2024

Lung Cancer Startup Maverix Medical Snaps Up Diagnostic Developer Cirrus Bio

Read More
PR Newswire
March 29, 2024
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
Read More
Wall Street Journal
November 30, 2023
Startup Ajax Health Extends Medtech Innovation Model to Hologic
Read More

Maverix Biopsy Tools

Sales Inquiries
Customer Care

About

We are developing a new class of steerable endobronchial instruments intended to help physicians navigate the airways and lung tissue and enable greater biopsy precision.

Unique Benefits

Increased Reach and Precision
Designed to reach ~4-5 cm beyond robotic catheters with steerability for targeting precision.
More Control Off-Airway
Designed for low-profile advancement off-airway, with fine distal control of the needle.
Improved Tool-in-Lesion Visualization
Designed to minimize imaging artifact on tool-in-lesion confirmation cone-beam CT.
Larger Tissue Samples
Designed with a trident-type Franseen FNB needle for greater sample yield than standard FNA needles.